Article
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
The Journal of clinical investigation - 1 Apr 1997
Wittrup H H, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard B G
Abstract excerpt
Lipoprotein lipase degrades triglycerides in plasma and as a byproduct produces HDL particles. Genetic variation in lipoprotein lipase may therefore affect cardiovascular risk. We tested 9,214 men and women from a general population sample and 948 patients with ischemic heart disease for the Asn291Ser substitution in lipoprotein lipase. The allele frequency in the general population was 0.024 and 0.026 for women...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
